The Liver Meeting 2019-Fertility and Contraception in Liver Disease: Recommendations for Hepatic Adenomas, Cirrhosis and Liver Transplant

Fertility and Contraception in Liver Disease: Recommendations for Hepatic Adenomas, Cirrhosis and Liver Transplant

Video Transcription

Video Summary

Dr. Monica Sarkar from the University of California, San Francisco presented on fertility and contraception in women with liver disease. The rising incidence of chronic liver disease in reproductive age women highlights the importance of discussing reproductive intentions. Dr. Sarkar covered various contraceptive options including combined hormonal contraception, progestin-only methods, and intrauterine devices, outlining their safety and efficacy in different liver conditions. She emphasized the need for liver providers to educate patients on changing fertility and the possibility of pregnancy across different liver disease severities. The presentation also addressed counseling for women post-liver or kidney transplants, highlighting the importance of proper family planning to ensure healthy outcomes. The CDC guidelines on contraceptive safety in liver disease and transplant settings were discussed, along with considerations for specific conditions like hepatic adenomas and Wilson's disease. Overall, the talk emphasized individualized care and shared decision-making for women with liver disease regarding contraception and pregnancy.

Asset Caption

Presenter: Monika Sarkar

Keywords

fertility

contraception

liver disease

reproductive intentions

contraceptive options

family planning